Anti-tumor Effect of Myxoma Virus on Human Gastric Cancer

GONG Wei,GU Jun,ZHOU Di,ZHAO Ming-ning,QUAN Zhi-wei,FANG Guo-en,LIU Ying-bin,Xueqing Lun,Peter Forsyth,Grant McFacdden,ZHANG Yong
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2012.12.039
2012-01-01
Abstract:Objective To investigate the anti-tumor effect of myxoma virus (MYXV) on human gastric cancer.Methods Four distinct gastric cancer cell lines were employed in this study,including AGS (primary gastric cancer cell),SNU-1 (metastatic gastric cancer celt derived from ascites),NCL-N87 (metastatic gastric cancer derived from liver),and KATO Ⅲ(metastatic gastric cancer cell derived from lymph node).Alamar blue test was applied to examine the anti-tumor effect of myxoma virus on gastric cancer cells.Western blotting was used to detect early and late viral replicate proteins,MT-7 and Serp-1.Intraperitoneal tumor model and subcutaneous tumor model were established in nude mice to investigate the in vivo anti-tumor effect of myxoma virus on gastric cancer.Results Myxoma virus exhibited anti-tumor effects on all four gastric cancer cell lines.The survival rate of four gastric cancer cells was 31.30% (AGS),33.98% (SNU-1),53.09% (NCL-N87) and 50.12% (KATO Ⅲ) respectively,which was significantly higher than that of NIH3T3 (P < 0.05).In vivo experiment also proved that myxoma virus showed significantly higher inhibitory effect on gastric tumor growth in both intraperitoneal tumor model and subcutaneous tumor model in nude mice than control group (P < 0.05).Conclusion Myxoma virus can spare normal cells but specifically kill human gastric cancer in vitro and in tumor nude mouse model.It might be a potential anti-tumor agent with high potency and safety.
What problem does this paper attempt to address?